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To the editor,
With great interest we have been following latest news 
and reports on clusters of paediatric patients displaying 
clinical features of hyperinflammatory shock and a possi-
ble association with a SARS-CoV-2 infection [1]. Although 
most children show only a mild and uncomplicated course 
of COVID-19, in a small subset of paediatric patients severe 
symptoms including hyperinflammatory state, persistent 
fever, circulatory shock, and evidence of organ dysfunction 
have been reported. This novel syndrome is still a puzzle 
for clinicians and scientists since its underlying pathology 
is poorly understood making targeted treatment and preven-
tive measures difficult. Similarities to children presenting 
with Kawasaki disease (KD) have been reported in some 
of these critically ill children while some of them predomi-
nantly display features of toxic shock, such as seen in severe 
staphylococcal or streptococcal infection. The RCPCH and 
CDC have published a case definition and scientists refer 
to this novel but still very rare severe clinical condition in 
children as “paediatric inflammatory multisystem syndrome 
temporally associated with SARS-CoV-2” (PIMS-TS).
While reflecting on this syndrome and its characteristic 
features, some interesting similarities come to mind when 
comparing the clinical course of PIMS-TS cases and the 
specific features of a disease in cats called feline infectious 
peritonitis (FIP) caused by the feline coronavirus (FCoV), 
an alphacoronavirus [2]. Both diseases show a predominance 
for the young. Cats are predominantly affected between 4 
and 16 months of age which would relate to children and 
young persons in humans. Initially, a seemingly harmless 
viral gastrointestinal infection of the cat turns into a life-
threatening systemic infection. Of particular note in this con-
text, in two case series gastrointestinal symptoms have been 
the predominant feature of early PIMS-TS disease in almost 
all children [1, 3]. In cats, enterocytes are initially infected 
causing mostly mild gastrointestinal disease; but in a subset 
of infected cats (about 5%) a severe systemic infection arises 
after a variable period of time ranging from 2 weeks up to 
several months. In FIP, fibrinous and granulomatous serosi-
tis, protein-rich serous effusion in body cavities and/or gran-
ulomatous lesions develop [2]. Most of the children in the 
PIMS-TS case series of Riphagen et al. also showed ascites 
and pleural effusions [1]. Histopathologically, a granuloma-
tous vasculitis is seen in FIP which relates to features of the 
Kawasaki syndrome although only small and medium sized 
vessels are primarily affected [2]. Furthermore, FIP shares 
additional features with severe COVID-19. Like in the 
human host, overexpression of inflammatory cytokines has 
been shown in FIP, particularly for TNF-α, IL-1β and IL-6 
[2, 4]. Infected and subsequently activated monocytes/mac-
rophages have been proposed to play a key role in this ful-
minant pathology [2]. In human COVID-19, these cytokines 
have been associated with a severe course of disease and 
deemed to be the hallmark cytokines of the cytokine storm. 
Infection of monocytes/macrophages with SARS-CoV-2 has 
been described, but it is still unclear whether these cells 
allow a permissive infection of the virus [5]. On the other 
hand, even non-permissive infection of macrophages and 
dendritic cells by SARS-CoV has been associated with sig-
nificant overexpression of pro-inflammatory cytokines [6]. 
In addition, similar findings in white blood cell count, such 
as lymphopenia possibly caused by TNF-α- mediated apop-
tosis, are equally detected in both conditions and have been 
described in many human COVID-19 cases as well as in 
FIP [2].
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The underlying pathophysiological mechanisms of FIP 
are still unclear. An in vivo mutation of FCoV affecting the 
viral spike protein (S-protein) and the occurrence of different 
pathogenic strains have been proposed in this context. On 
this note, it would be of great interest to see whether muta-
tions in the viral genome, particularly in regions affecting 
the S-protein of SARS-CoV-2, could lead to a change in cell 
tropism enabling the virus to more effectively infect and rep-
licate within human monocytes/macrophages subsequently 
leading to the clinical picture of PIMS-TS. Unfortunately, 
results on the pathological and histopathological examina-
tions on patients with PIMS-TS, i.e. post-mortem pathology, 
are still missing. Closing this knowledge gap could help to 
clarify the underlying mechanisms of this challenging con-
dition. Finally, RNA expression profiling of these cases in 
comparison to milder ones, like currently underway in the 
DIAMONDS study (https ://www.diamo nds20 20.eu), will 
certainly add critical information on this aspect in the near 
future. Despite the fact that SARS-CoV-2 belongs to the 
genus of betacoronavirus and FCoV to the genus of alphac-
oronavirus the common link for both disease manifesta-
tions is the occurrence of multi-system vasculitis involving 
monocytes and macrophages as possible key players in the 
pathogenesis. With regards to other coronavirus infections, 
only for ferret systemic coronavirus (FRSC) a similar dis-
ease entity has been reported which closely resembles the 
non-effusive (dry) form of FIP. Interestingly, also in SARS-
CoV infection a vasculitis with infiltration of monocytes and 
involvement of small veins has been described, a character-
istic feature of FIP [7]. Other human and animal coronavi-
ruses usually cause gastrointestinal (e.g. canine coronavirus, 
transmissible gastroenteritis virus) and/or respiratory dis-
ease (e.g. canine respiratory coronavirus, human coronavirus 
OC43) varying in individual degree of severity [8]. Infec-
tion of cats with SARS-CoV-2 is possible but up to now no 
infected animals showing symptoms and signs resembling 
FIP or PIMS-TS have been reported.
Even though currently known receptors for both viruses, 
ACE-2 and aminopeptidase N, are different, it has not been 
described that binding to these receptors triggers a receptor-
specific effect besides mediating cell entry. Furthermore, the 
receptor for the type I of FCoV is not known yet. Although 
exact pathophysiological pathways of both viral infections 
are unfortunately still unclear, both viruses seem to have 
the potential to manipulate and evade the innate immune 
response by means such as the production of accessory pro-
teins (e.g. accessory proteins 7a, 3a, 3b and non-structural 
protein 5 (nsp5) in the case of FCoV) or by interfering with 
the antiviral type I interferon response resulting in a ham-
pered or delayed activation of this process [9, 10]. In the 
case of nsp5, this effect is mediated via negatively affecting 
the RIG-I-like receptor pathway which has also been shown 
for SARS-CoV and is also likely to play a role in SARS-
CoV-2 infection [10, 11].
In our opinion, both viruses essentially manipulate 
the infected monocyte/macrophage leading to enhanced 
cytokine production. This results in an optimized environ-
ment for viral replication due to induced T-cell apoptosis 
and upregulation of both ACE-2 and aminopeptidase N, 
respectively. From a monocytic perspective, the cell is essen-
tially locked in cytokine overdrive. Interestingly, remdesivir, 
currently the only drug with proven benefit on the clinical 
course of COVID-19, has also been successfully been used 
in the treatment of FIP.
We propose that FIP could be a promising veterinary 
disease to learn more about SARS-CoV-2 activity in mono-
cytes/macrophages and help to elucidate the mechanisms 
underlying the profound production of cytokines resulting 
in a severe cytokine storm and PIMS-TS.
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